AdvaMed chairman-elect Collins
This article was originally published in The Gray Sheet
Executive Summary
Medtronic Chairman & CEO Art Collins will be named incoming AdvaMed chairman for 2004 and 2005 at the device trade group's annual meeting March 19-22 in Aventura, Fla. Collins previously testified on behalf of AdvaMed to the House Ways & Means/Trade Subcommittee on expanding Japanese market opportunities (1"The Gray Sheet" Oct. 29, 2001, p. 9)...
You may also be interested in...
Shorten Device Payment Timeframe, Develop Criteria, U.S. Presses Japan
Japan's current preoccupation with orthopedic industry pricing practices is distracting the government from pursuing approval and reimbursement reforms for breakthrough devices, according to AdvaMed.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.